$PFE: Palbociclib maint study blowing up (tonight) is a material drag to all outer year numbers. Focus will now turn to major patent cliffs of Eloquis and Palbociclib, $PFE's largest drugs.  $PFE likely needs to make major acquisitions in the very near term.